The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

This was the first time a mutated gene has been restored to normal. The small study of nine patients announced Monday by the company Beam Therapeutics of Cambridge, Mass., involved fixing a ...

During a live event, Alexander I. Spira, MD, PhD, and participants discuss efficacy, adverse events, and sequencing of EGFR-mutated NSCLC treatments.